Table 1.

Study schedule.

Required measurements	Before registration	During protocol treatment											Discontinuation of protocol treatment
		Chemotherapy								Surgery
		Course	1			2			If chemotherapy is continued	Before surgery	During surgery	28 days after surgery
		Day	1	8	15	29	36	43
Patient characteristics	○
Performance status	○		○	○	○	○	○	○	○	○
Symptoms	○		○	○	○	○	○	○	○	○
Blood count	○		○	○	○	○	○	○	○	○
Blood biochemistry	○		○	○	○	○	○	○	○	○
CEA, CA19-9	○								○	○
ECG	○
QOL assessment	○										○	○	○
Contrast CT scan	○									○	○
Administration record
Gemcitabine			○	○	○	○	○	○	○
Nab-paclitaxel			○	○	○	○	○	○	○
Adverse events				○	○	○	○	○	○	○
Operative findings											○
Postoperative complications												○
Pathological findings												○

CEA, carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9; ECG, electrocardiogram; QOL, quality of life; CT, computed tomography.